Skip Navigation



JAC Advance Access published online on November 6, 2009
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkp415
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eisenhut, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisenhut, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Letter to the Editor

Comment on: Swine flu and antibiotics

Michael Eisenhut*

Luton & Dunstable Hospital NHS Foundation Trust, Lewsey Road, Luton LU4 ODZ, UK

* Tel: +448451270127; E-mail: michael_eisenhut@yahoo.com

Key Words: procalcitonin , influenza H1N1 , antibiotics

The first 10% of the full text of this article appears below.

Sir,

In a recent article, Barlow commented on behalf of the British Society for Antimicrobial Chemotherapy on Department of Health guidance on antibiotic use in suspected H1N1 influenza.1 Concerns were expressed that the indiscriminate use of broad-spectrum antibiotics would undermine strategies to reduce emergence of Clostridium difficile and methicillin-resistant Staphylococcus aureus infections.1 The authors mentioned that . . . [Full Text of this Article]


   Transparency declarations
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?